121 related articles for article (PubMed ID: 3587729)
21. Study of the in vitro activity of norfloxacin and other drugs on amoxicillin-resistant uropathogenic isolates.
Piccolomini R; Allocati N; Catamo G
Chemioterapia; 1984 Jun; 3(3):167-72. PubMed ID: 6241505
[TBL] [Abstract][Full Text] [Related]
22. [Antibiotic resistance at a hospital environment. Observations from 1980 to 1986].
Pistono PG; Piro F; Guasco C; Malcangi A; Martinetto P
G Batteriol Virol Immunol; 1987; 80(1-12):25-168. PubMed ID: 3509032
[TBL] [Abstract][Full Text] [Related]
23. Incidence of multiple antibiotic resistant Gram-negative bacteria isolated from surface and underground water sources in south western region of Nigeria.
Oluyege JO; Dada AC; Odeyemi AT
Water Sci Technol; 2009; 59(10):1929-36. PubMed ID: 19474486
[TBL] [Abstract][Full Text] [Related]
24. Comparative in-vitro antibacterial activity of aztreonam against clinical isolates of gram-negative bacteria.
Shibl AM; Ishag AH; Durgham SM
J Chemother; 1989 Jul; 1(4 Suppl):359-61. PubMed ID: 16312439
[No Abstract] [Full Text] [Related]
25. Susceptibility of 89,517 gram-negative isolates to aztreonam and other antibiotics.
Lindsay G; Woods P
Chemioterapia; 1987 Jun; 6(2 Suppl):106. PubMed ID: 3509363
[No Abstract] [Full Text] [Related]
26. Changes in resistance to aminoglycoside antibiotics of different bacterial strains isolated during the period 1978 to 1983. Netilmicin as alternative therapy.
Bovelacci A; Montini G; Ramacciotti PG
Chemioterapia; 1985 Dec; 4(6):439-44. PubMed ID: 3830413
[TBL] [Abstract][Full Text] [Related]
27. [In vitro evaluation of the antibiotic effect of imipenen on bacterial strains isolated mostly from compromised patients].
Bartolucci M; Galluzzi F; Sanchioni G; Aureli G
Quad Sclavo Diagn; 1988; 24(1-4):203-12. PubMed ID: 3268913
[TBL] [Abstract][Full Text] [Related]
28. [In vitro activity of norfloxacin against gram-positive and gram-negative organisms from recent clinical isolates].
Mancini C; Brenciaglia MI; Ghezzi MC; Giordano A; Nazzari C; Cipriani P
Boll Ist Sieroter Milan; 1985; 64(4):289-93. PubMed ID: 3935135
[TBL] [Abstract][Full Text] [Related]
29. [Triangular comparison of the agar diffusion method, the ABAC system and the Sensitre system for determination of bacterial sensitivity to aminoglycoside chemoantibiotics].
Sala A; Raffaele L; Cappello P
Quad Sclavo Diagn; 1981 Mar; 17(1):100-8. PubMed ID: 7313065
[TBL] [Abstract][Full Text] [Related]
30. [Distribution and drug-resistance of 3 500 gram-negative bacteria in Guangzhou].
Xiao QZ; Su DH; Jiang JH; Zhong NS
Di Yi Jun Yi Da Xue Xue Bao; 2005 Feb; 25(2):132-8. PubMed ID: 15698988
[TBL] [Abstract][Full Text] [Related]
31. Investigation of the antibiotic susceptibility patterns of pathogens causing nosocomial infections.
Yaman A; Tasova Y; Kibar F; Inal AS; Saltoglu N; Buyukcelik O; Kurtaran B; Dundar IH
Saudi Med J; 2004 Oct; 25(10):1403-9. PubMed ID: 15494811
[TBL] [Abstract][Full Text] [Related]
32. Microbiology of diabetic foot infections in a teaching hospital in Malaysia: a retrospective study of 194 cases.
Raja NS
J Microbiol Immunol Infect; 2007 Feb; 40(1):39-44. PubMed ID: 17332905
[TBL] [Abstract][Full Text] [Related]
33. Antibacterial activity of aztreonam: a synthetic monobactam. A comparative study with thirteen other antibiotics.
Paradelis AG; Stathopoulos GA; Salpigides GN; Crassaris LG
Methods Find Exp Clin Pharmacol; 1983; 5(6):375-83. PubMed ID: 6684718
[TBL] [Abstract][Full Text] [Related]
34. [Chemobiotic sensitivity of common Gram-negative bacteria in urinary tract infections, 1981-1982].
Mastandrea P; Delli Carri P
Quad Sclavo Diagn; 1983 Dec; 19(4):455-62. PubMed ID: 6377362
[TBL] [Abstract][Full Text] [Related]
35. Epidemiology of resistance to netilmicin and other aminoglycosides.
Toscano MA; Russo G; Nicoletti G; Stefani S; Geraci C; Alessandria E
Chemioterapia; 1986 Jun; 5(3):191-5. PubMed ID: 3719853
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of antimicrobial activity of beta-lactam antibiotics using Etest against clinical isolates from 60 medical centres in Japan.
Ishii Y; Alba J; Kimura S; Shiroto K; Yamaguchi K
Int J Antimicrob Agents; 2005 Apr; 25(4):296-301. PubMed ID: 15784308
[TBL] [Abstract][Full Text] [Related]
37. [Is aztreonam could become "a challenger" for treatment of Gram negative infections? May be an answer from microbiological data: in vitro study including 36,485 strains of enterobacteria and Pseudomonas].
Honderlick P; Gravisse J; Dardelle D; Cahen P
Pathol Biol (Paris); 2007 Dec; 55(10):475-7. PubMed ID: 17904768
[TBL] [Abstract][Full Text] [Related]
38. [Antibiotic sensitivity of gram-negative bacteria in intensive care units in Switzerland].
Wüst J; Auckenthaler R; Breer C; Frei R; Heinzer I; Kamm W
Schweiz Med Wochenschr; 1994 Oct; 124(39):1695-700. PubMed ID: 7939535
[TBL] [Abstract][Full Text] [Related]
39. [Analysis of the etiological structure and dynamics of antibiotic resistance in the causative agents of suppurative inflammatory diseases in the patients at a large general hospital].
Kuznetsova SM; Samoĭlova LN; Speranskaia ON; Abadzhieva AN; Fomina IP
Antibiotiki; 1984 Aug; 29(8):605-13. PubMed ID: 6486756
[TBL] [Abstract][Full Text] [Related]
40. In vitro study of the sensitivity of 1030 hospital-isolated bacterial strains to aztreonam.
Grassi L
Chemioterapia; 1984 Aug; 3(4):262-6. PubMed ID: 6543433
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
